ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
Project Title |
Institution / Principal Investigator(s) | Grant Type | Year | State |
|---|---|---|---|---|
| Targeting eEF2 Kinase in Neuroblastoma | University of California San Francisco / William Weiss, M.D., Ph.D. | Innovation Grants | 2014 | California |
| Targeting Eya2 to Inhibit c-Myc driven Medulloblastoma Tumor Progression | University of Colorado Denver / Melanie Vincent, PhD | Young Investigator Grants | 2016 | Colorado |
| Targeting Fusion-driven Sarcomas | National Institutes of Health / Javed Khan, MD | Crazy 8 Pilots | 2019 | Maryland |
| Targeting Glutamine Addiction in Diffuse Intrinsic Pontine Gliomas (DIPGs) | University of Michigan / Sriram Venneti, MD/PhD | Innovation Grants | 2018 | Michigan |
| Targeting Glutamine Metabolism in MYC Driven Atypical Teratoid Rhabdoid Tumors | The Johns Hopkins University School of Medicine / Jeffrey Rubens, MD | Young Investigator Grants | 2017 | Maryland |
| Targeting HMGA1 in Childhood ALL | The Johns Hopkins University School of Medicine / Amy M. Belton, PhD | Young Investigator Grants | 2011 | Maryland |
| Targeting HMGA1 in Pediatric T-cell Acute Lymphoblastic Leukemia | The Johns Hopkins University School of Medicine / Joelle Hillion, PhD | Young Investigator Grants | 2008 | Maryland |
| Targeting inhibitory phosphatase signaling in high-risk childhood ALL | University of California San Francisco / Markus Muschen, MD, PhD | Innovation Grants | 2011 | California |
| Targeting KDM6B in Pediatric Leukemia | Washington University / Grant A. Challen, MD/PhD | Innovation Grants | 2018 | Missouri |
| Targeting mechanisms of Siglec15-mediated immune evasion in hematologic malignancies | Emory University / Christopher Porter, MD, Curtis Henry, MD & Christopher Flowers, MD | Innovation Grants | 2019 | Georgia |
